28th -29th March 2023, Hotel TipTop International, Pune







We deliver and implement rapid and cost-effective Biomanufacturing solutions from early phase development through scale-up to commercial manufacturing. Benefit from the most comprehensive bioprocess technology portfolio coupled with our expertise in Single-use bioprocess engineering. Our global bioprocess teams are available to discuss your process development and manufacturing requirements.



Since its inception, Hanbon Technology has been adhering to the original intention to provide biopharmaceutical users with drug purification equipment and services based on chromatography technology. The main products are: Biopharmaceutical downstream purification equipment, Industrial preparative liquid chromatography systems, Supercritical fluid chromatography systems, Continuous chromatography systems, Small nucleic acid synthesis and purification equipment, and can provide users with chromatography products as the core of the overall solutions and services. For more than 20 years, Hanbon has been following the wave of biopharmaceutical development, constantly developing new products and meeting the emerging needs of the market, providing R&D and production equipment for synthesis, purification and delivery of emerging small nucleic acid drugs, mRNA vaccines, cell therapy drugs, etc.
Website link: http://www.hanbon.com.cn/en/





FedEx Express is the world's largest express transportation company, providing fast and reliable delivery to more than 220 countries and territories. FedEx Express uses a global air-and-ground network to speed delivery of time-sensitive shipments.
Connecting people with goods, services, and ideas creates opportunities and improves lives. At FedEx, we believe that a connected world is a better world, and that belief guides everything we do.
Consistently ranked among the world’s most admired and trusted employers, FedEx inspires its team members to remain focused on safety, the highest ethical and professional standards and the needs of their customers and communities. FedEx is committed to connecting people and possibilities around the world responsibly and resourcefully, with a goal to achieve carbon-neutral operations by 2040.
FedEx started operations in India as an independent carrier in 1997 and has since continued to play a crucial role in developing India’s express transportation industry. FedEx Express operates 38 weekly international cargo flights to and from India from Mumbai, Delhi, and Bangalore, connecting customers to our global air network. Today, FedEx Express continues to enhance its services and solutions in India, based on the needs of our customers, to offer unparalleled connectivity and access to global markets.





Datwyler is a leading industrial supplier and a key player in the global health care world.
Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum
seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
For more infromation, please visit: https://datwyler.com/





Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
For more information about Pfanstiehl Inc, and their products and solutions, please contact us at [email protected] or visit www.Pfanstiehl.com”



Tower delivers proven physical and temperature protection for pharmaceutical and life science products and our robust, reliable, and reusable containers are the essential link in the stability of the cold chain.
Headquartered in the UK, we operate a global network ensuring availability and easy access to our products for all customers.
We are trusted by global pharmaceutical, logistics and airline companies and our experienced team, supported by a centralized quality-management system, reinforces customer confidence that our shipping facilities will meet requirements throughout the supply chain. Our patented design technology ensures our solutions meet the pharmaceutical industry performance standard, providing a minimum of 120 hours temperature compliance in any environment, anywhere in the world.
We work closely with our customers, realizing their requirements and how we can address emerging needs. and to deliver customer-focused innovation in temperature-controlled protection.



Pharmaceutical industries have stringent regulations when it comes to quality and safety.
In order for businesses to remain competitive in this industry, they need accurate and
fast microbial contamination detection solutions that are adaptable and cost-effective.
bioMérieux helps the pharmaceutical and healthcare industries unlock greater value from
their organizations through a complete line of diagnostic solutions that enable more rapid,
consistent results. Reliable and quick results improve safety, enhancing your brand
protection, and maintenance of safer pharmaceutical products. bioMérieux solutions
protect your product quality.



Merck, a life science leader, is a business of Merck KGaA, Darmstadt, Germany. Our products and services help you safely and efficiently develop and manufacture therapeutics.
Our BioReliance® Biosafety Testing Services offer comprehensive and integrated services that support every phase of the testing, development and manufacturing process.
Your Therapy, Our Priority
Your Trusted Partner for Innovative Biosafety Testing, Cell Banking, Viral Clearance and Product Characterization
Visit our Merck booth.
Speak to us, and learn more:
www.sigmaaldrich.com/
Science and Lab Solutions (SLS) provides a more seamless experience to customers as they continue to benefit from our scientific expertise and access to one of the broadest portfolios in the industry.
https://bit.ly/








Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services, for primary container, injection, infusion therapy devices, and contract development and manufacturing services (CDMO).
We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral
drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for
all parenteral applications. We provide sterile injectable contract development and manufacturing (CDMO) services from initial combination device design and formulation development to commercial manufacturing.
supporting better patient outcomes around the world.
We listen. We question. We deliver.






Since 1998, Ami Polymer is in the business of Silicone Elastomeric products and also, other Polymeric components which ultimately provide solutions to Fluid Transfers, Sealing, and Contamination controls for Biopharma, Pharma, Medical, Laboratory, Food, Beverages, and Engineering sectors worldwide. We Are Experts in Silicone Tubing, Hoses & Single-Use Assemblies.
Ami Polymer is having ISO Class VII and ISO Class VIII Cleanroom facilities certified with ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 27001:2013, ISO 13485:2016. We also have a BPOG extractables program for our products for regulatory markets worldwide.



Everything began with a commitment to serve the life sciences and healthcare industries by offering global transport and innovative temperature-controlled logistics solutions. Being one of the market leaders in our sector and dedicated to the clinical trial and cell & gene therapy communities, we are operating in more than 150 countries intending to improve the health of people around the world. Truly focused on our customer and patient needs, we, through a dedicated team, plan, manage and implement a tailor-made temperature-controlled solution to fit your requirements and business goals. Count on us to deliver your life-saving goods worldwide - Count on CRYOPDP!
CRYOPDP video: https://www.youtube.






With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products.
SGS provides a comprehensive range of biosafety services such as: virology, cell and molecular biology, microbiology and TEM. Health Authorities (US FDA and the EMA), require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses and other potential contaminants. SGS ensures product safety in satisfying these regulatory requirements.
Website: https://www.sgs.com/en/our-



Centre for Cellular and Molecular Platforms (C-CAMP) is India’s premier innovation and technology hub and one of the largest and most vibrant life sciences incubators in the country. C-CAMP has directly funded, incubated and mentored 350+ start-ups over half a decade and is connected to over 2000 start-ups and entrepreneurs across the country in healthcare, agriculture and environment. C-CAMP has established 15 state-of-the-art technology platforms for facilitating cutting-edge research in the biosciences which have supported 230+ publications. C-CAMP is an initiative supported by Govt of India agencies including Department of Biotechnology, Department of Science & Technology, NITI Aayog-AIM, Ministry of Electronics and Information Technology, Startup India and Department of IT, BT, S&T Government of Karnataka. It has several international partnerships spread across US, UK, Netherlands, Denmark, Switzerland, Japan, Brazil and Israel.

















Dr Ranjan Chakrabarthi





Dr. Milind Gore



Dr Ivana Haluskova





Dhananjay Patankar
Dr. Dhananjay Patankar is a Chemical Engineer with over 25 years’ experience and has played a significant part in the growth of the Indian biopharmaceutical industry.Most recently he was heading the Biologics CDMO business of Syngene International based in Bangalore.Under Dr. Patankar’s leadership Syngene’s biologics facilities received EU-GMP certification and supplied several products for clinical trials in US, Europe, India and elsewhere.Currently Dr. Patankar is an independent consultant working with Syngene as well as other organizations, supporting various aspects of biopharmaceutical development and manufacturing.
Prior to Syngene, Dr. Patankar held leadership positions at Intas Biopharmaceuticals and the Biotech division of Wockhardt, and was responsible for the development and manufacturing of several biosimilars for the Indian and global markets, including India’s first biosimilar approved for marketing in Europe and India’s first EU-GMP certified biologics manufacturing facility.He has served in various national committees and biotechnology industry bodies in India, and was a Biologics Expert Committee member at the US Pharmacopeia from 2011 till 2020.



Dr. Kate O’Brien, MD, MPH
Dr Kate O’Brien is Director of the Immunization, Vaccines and Biologicals Department at the World Health Organization. In this role she is responsible for leading WHO’s strategy and implementation to advance the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and wellbeing. Dr O’Brien also serves as WHO’s Technical Lead of the COVID Vaccine Pillar (COVAX), a part of the Access to COVID Tools Accelerator (ACT-A). COVAX aims to support countries to achieve their goals toward the Global COVID-19 Vaccine Strategy for 2022, released by WHO and the UN Secretary General in October 2021. It establishes the health, social and economic goals of the vaccine effort and establishes a target of 70% full vaccine coverage by mid-2022.
Dr O’Brien is a Canadian who trained as a pediatric infectious disease physician, epidemiologist and vaccinologist. She earned her BSc in chemistry from University of Toronto (Canada), her MD from McGill University (Canada), and her MPH from Johns Hopkins Bloomberg School of Public Health (USA).



Dr. Bakulesh Khamar



Dr GVJA Harshvardhan



Dr. Jaby Jacob



Dr Kutub Mahmood



Dr Preetha Rajaraman



Dr Sandeep Majumdar



Dr Sarah McMullen



Dr Shirshendu Mukherjee



Dr SK Jana



Dr Sudeep Kumar



Dr Vibha Jawa



Dr Vipul Doshi



Prasad Deshpande



Prof. Rahul Purwar



Prof. Rahul Purwar



Rajinder Kumar Suri



Samir Desai



Abhishek Mathur
Abhishek Mathur is currently working as the Chief Scientific Officer at Biolexis Pvt Ltd (A Strides Group Company), and is based in Bangalore, India. At Biolexis, Abhishek is responsible for leading CMC, Regulatory and Clinical strategy for end-to-end development and commercialization of biological therapeutics with special focus on regulated markets. In the role, Abhishek is also responsible for identifying in-licensing opportunities for early phase biological products & product cell lines, and developing a robust product pipeline for Biolexis. Abhishek has over 16 years of experience in leading biologics development at top tier biopharma companies like Amgen and Regeneron in the USA. During his stints in these organizations, he has successfully led multiple novel Biologics & Biosimilar programs from preclinical stage through commercialization. Further, in these roles he also established and led several strategic external partnerships with several CDMOs across the globe. Abhishek holds PhD in Biological Sciences from Northwestern University (USA), Bachelors of Technology in Chemical Engineering from IIT Bombay (India) and an MBA from Duke University (USA).



Dr Ajitkumar K Sudke



Dr Ashish Sahai



Dr Anurag . S Rathore



Dr A Ramkishan





Dhananjay Patankar
Dr. Dhananjay Patankar is a Chemical Engineer with over 25 years’ experience and has played a significant part in the growth of the Indian biopharmaceutical industry.Most recently he was heading the Biologics CDMO business of Syngene International based in Bangalore.Under Dr. Patankar’s leadership Syngene’s biologics facilities received EU-GMP certification and supplied several products for clinical trials in US, Europe, India and elsewhere.Currently Dr. Patankar is an independent consultant working with Syngene as well as other organizations, supporting various aspects of biopharmaceutical development and manufacturing.
Prior to Syngene, Dr. Patankar held leadership positions at Intas Biopharmaceuticals and the Biotech division of Wockhardt, and was responsible for the development and manufacturing of several biosimilars for the Indian and global markets, including India’s first biosimilar approved for marketing in Europe and India’s first EU-GMP certified biologics manufacturing facility.He has served in various national committees and biotechnology industry bodies in India, and was a Biologics Expert Committee member at the US Pharmacopeia from 2011 till 2020.



Elena Smith



Dr Farshad Guirakhoo



Dr. Indrapal Reddy Addela,



Dr Jayanta Bhattacharya



Dr Manoj Chhikara





Dr. Milind Gore



Dr. Niraj V Shende





Dr Ranjan Chakrabarthi



Dr Ravi Prakash Mathur



Dr Raj Shankar Ghosh



Dr Ratnesh Jain



Dr Ravi Ganapathy



Dr Sanjeev Gupta, Ph.D.,



Dr Shaligram Rane



Shashwati Basak Phd
Dr Shashwati Basak has a PhD in Molecular and Cell Biology and two postdoctoral fellowships in gene expression, regulation and cancer signalling pathways from Salk Institute for Biological Sciences and Stanford University. She has 20+ years of scientific leadership experience in translational research, clinical biomarkers, analytical assays and technology platforms. She has worked in several Biotech / Biopharma companies including Biocon Bristol Myers-Squibb R & D center, Aurigene Discovery Technologies and Immuneel Therapeutics Ltd and held positions of increasing responsibilities, in varied roles. Currently, as an Independent Consultant, her focus is on various aspects of drug development, especially in Cell and Gene Therapy, including Quality and Compliance in CGT.



Dr Sunil Gairola



Dr. Sumeet Juneja



Dr Subhadeep Sinha



Dr Sudarshan Reddy



Dr Sumant Karnik



Dr Suresh Beri, Addnl.



Dr Upendra Jani



Dr Vasan Sambandamurthy



Ashwini Bhisikar



Darshana Jain



Dorcas Noertoft



Kiran Deshmukh



Kumar Gaurav



Peter Tygesen
Peter Holm Tygesen is an organic chemist by training. He has more than 30 years of pharmaceutical management experience. Notably he has worked at Lundbeck for more than 13 years in different positions in R&D and production management. He has also served as CEO of the Biotech company Egalet and Riemann before becoming the CEO of Biosector Brenntag, and successfully led the integration of Biosector as Managing Director Croda Denmark after the acquisition by Croda International Plc. Most recently he assumed the role of Global Business Director for Croda’s Vaccine Adjuvant Systems platform within Croda Pharma. He excels in driving change management and in interacting with partners and authorities.



Prof. S.S. Vasan



Prabhaharan Sankaran



Rajendra Vidwans



R. Chandi Prasad



Mrunal Gosavi



Nithin Chopra



Vishal Sonje



Venkat Ramana


The Great Indian Biologics Festival 2023 is THE venue for the life sciences community to come together to bridge the gap between R&D, process development, and bioprocessing of vaccines and biologics for emerging markets. The event aims to bring together all stakeholders from India and Asia and also discuss regulatory, new product innovation, latest developments to aid manufacturing and operations, supply chain logistics, and best go-to-market strategies.





FedEx Express is the world's largest express transportation company, providing fast and reliable delivery to more than 220 countries and territories. FedEx Express uses a global air-and-ground network to speed delivery of time-sensitive shipments.
Connecting people with goods, services, and ideas creates opportunities and improves lives. At FedEx, we believe that a connected world is a better world, and that belief guides everything we do.
Consistently ranked among the world’s most admired and trusted employers, FedEx inspires its team members to remain focused on safety, the highest ethical and professional standards and the needs of their customers and communities. FedEx is committed to connecting people and possibilities around the world responsibly and resourcefully, with a goal to achieve carbon-neutral operations by 2040.
FedEx started operations in India as an independent carrier in 1997 and has since continued to play a crucial role in developing India’s express transportation industry. FedEx Express operates 38 weekly international cargo flights to and from India from Mumbai, Delhi, and Bangalore, connecting customers to our global air network. Today, FedEx Express continues to enhance its services and solutions in India, based on the needs of our customers, to offer unparalleled connectivity and access to global markets.















JNC CORPORATION / MR SANGHAVI & CO. We are in the business of providing Biotech, Pharma, Fine Chemicals & Academia solutions. With state of the art chromatography bulk media, resins, gels & equipment’s from the world’s best companies, we offer the best technical solutions & support. The Cellufine™ product line offers a broad range of chromatography resins for the purification of proteins, enzymes, and biomolecules. The media based on spherical cellulose beads, exhibits high chemical stability / mechanical strength, higher flux and inherently bio-compatible. Applications include protein / polysaccharide purification, endotoxin removal, and used worldwide purifying vaccines, therapeutic enzymes, and virus concentration / purification. Cellulose media have significantly lower Leachable than comparable polymeric beads. Gel Filtration, IEX, Affinity, and HIC media available for broad range of biomolecules and applications. Cellufine customizes media / ligands, bead sizes for challenging purification process. Besides growing and consolidating the business of international marketing of industrial products and chemical specialties, we undertake backward/forward integration activity to produce tailor-made value-added specialty products. “Our mission is to become a benchmark organization in this line of business by striving consistently to develop our organization, professional skills & infrastructure as to be highly effective in this competitive environment.” Mr. Rajiv Sanghavi Director JNC CORPORATION/MR SANGHAVI & CO. 28, Sarvodaya Industrial Estate, Near Paper Box, Off. Mahakali Caves road, Andheri East, Mumbai – 400093 Mobile : +91-9323990409 Email : [email protected] Website : www.mrsanghavico.com



Pall Corporation provides critical filtration, separation, and purification solutions to meet the demanding needs of a broad spectrum of life sciences and industrial customers around the globe. Across 80 locations and 10,000 people worldwide, we are unified by a singular drive: to solve our customers' biggest fluid management challenges. And in doing so advance health, safety, and environmentally responsible technologies. Together, our Life Sciences and Industrial teams serve a diverse range of customers including biotechnology, pharmaceutical, medical, food and beverage, laboratory, microelectronics, aerospace, fuels, petrochemical, chemical, automotive and power generation industries. Our industry-leading technologies and solutions are at work in countless applications, protecting critical operating assets, improving product quality, safeguarding the health, and minimizing emissions and waste
For more info, please check: https://www.pall.com/en/biotech.html





We deliver and implement rapid and cost-effective Biomanufacturing solutions from early phase development through scale-up to commercial manufacturing. Benefit from the most comprehensive bioprocess technology portfolio coupled with our expertise in Single-use bioprocess engineering. Our global bioprocess teams are available to discuss your process development and manufacturing requirements.





Datwyler is a leading industrial supplier and a key player in the global health care world.
Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our healthcare offering, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum
seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
For more infromation, please visit: https://datwyler.com/



Ami Polymer Pvt. Ltd. is one of the leading manufacturers and suppliers of Biopharmaceuticals and silicone-based products in India . Established in the year 1998 in Mumbai, India, our company has been acclaimed for quality and excellence in the range of products offered. We employ efficient supply chain management system and have committed ourselves to deliver the finest products on time to our valuable customers.
We are an ISO 9001:2015,ISO 14001:2015 & ISO 45000-2018 ,TUV Nord Certified company, having a cleanroom of 25000 sq. feet area, supplying the finest quality range of biopharmaceuticals grade Elastomer Tubing, Reinforced Hoses, Inflatable Gaskets, Extruded & moulded components and single use assemblies as per USFDA standards.
Know more about us at :- www.amipolymer.com
Primary Contact :- Mr. Chandan S./Mrs. Aswathy Nair
Email id :- [email protected]/[email protected]
Designation :- Sr. Manager Business Devlopment / Sr. Executive International Marketing



West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. With almost 10,000 team members across 50 sites worldwide, West helps support our customers by delivering over 40 billion components and devices each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a century, West in its fiscal year 2020 generated over $2.147 billion in annual revenue. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.



Our Purpose is to use our Smart science to improve lives™. We combine our knowledge, passion, and entrepreneurial spirit to create, make, and sell sustainable speciality ingredients that are relied upon by industries and consumers everywhere since 1925.
For nearly a hundred years, Croda has been a world-leading specialist for high-quality pharmaceutical excipients and vaccine adjuvants, serving the major human vaccines and medication producers globally. Today, we supply adjuvants and high purity pharmaceutical excipients to 12 of the 19 currently approved Covid-19 vaccines.
To learn more about what Croda Health Care offers, visit us at: https://bit.ly/3r4hn6z



Roquette is a global leader in plant-based ingredients, a pioneer of plant proteins and a leading provider of pharmaceutical excipients. The group addresses current and future societal challenges by unlocking the potential of nature to offer the best ingredients for food, nutrition and health markets. In collaboration with customers who are also passionate about the ongoing food revolution, Roquette contributes to developing a whole new gastronomy that meets consumers’ demands. In the pharma sector, Roquette offers solutions that play a critical role in medical treatments that cure and save lives. Thanks to a constant drive for innovation and a long-term vision, the group is committed to improving the well-being of millions of people all over the world while taking care of resources and territories. Founded in 1933, Roquette is a family-owned company which operates in more than 100 countries, has a turnover of around 3.5 billion euros, and employs 8,360 people worldwide.
Website - Roquette
Linked in - Roquette Pharma Solutions



Shimadzu Corporation, Japan founded in 1875 and having a history of more than 145 years, is one of the leading Manufacturers & suppliers of Analytical, scientific & testing instruments such as Chromatography, Mass-Spectrometry, Spectroscopy, Testing instruments, Environmental monitoring instruments. Shimadzu Analytical (India) Pvt Ltd, a wholly owned subsidiary of Shimadzu Corporation, Japan, offers an extensive range of instruments, value added services & customer support.
Shimadzu has been serving the Indian scientific community since many decades now, through its well-established network of distributors namely Toshvin Analytical, Spinco Biotech, Swan Environmental, Amkette Analytics & Perfomax Analytical for various product ranges.
The Customer Support Centres (CSC) in India were established in Mumbai (2006) & New Delhi (2008) to reaffirm the commitment towards our valued customers. Our state-of-art facility showcases a wide range of analytical instruments with the key objective of providing application support & continuous technical training for analytical scientists to offer the best possible solutions to face the challenges faced by the analysts.



SKAN is a Swiss company and a global market and technological leader for isolators and decontamination processes for the aseptic production of biopharmaceutical substances. SKAN’s core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products.
Website: www.skan.com www.pharmalab.com



ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics, vaccines, and diagnostics. The company employs an application-oriented development strategy, with a particular focus on product design, quality control and solution-based support. Our products and services enable anyone in the field of drug development to have a more intuitive and streamlined process.
ACROBiosystems' catalog includes a comprehensive list of disease-associated biomarkers and drug targets from humans to other common species. All of our products are produced with high quality and batch-to-batch consistency to satisfy the rigorous standards of pharmaceutical research and development.
As ACROBiosystems' only distributor in India, Allianz BioInnovation is an ISO 9001: 2015 Certified Biotech company offering innovative Life Science Research tools from renowned companies across the world who are world leaders in their respective fields. The company has gained recognition, success and growth to its present position of a leading distributor as a result of our focus on scientist’s research needs and by following three principle viz; value, service and support.
URL link/website: https://www.acrobiosystems.com/



Aeris dynamics packaging was established in Singapore in the year 2001. We are specializing in research, design, test, manufacture, validation, and implementation of cold chain insulated packaging system for the pharmaceuticals, biomedical science, vaccine, clinical trials, medical, diagnostics and healthcare markets.
Aeris now offers it service from 9 locations India, Singapore, Malaysia, South Korea, China, Thailand, Hong Kong, Gulf and Australia. Aeris offers both standard and customize shipping system designed to ensure the integrity upon arrival of sensitive vaccines, drugs enzymes, blood, diagnostic specimens, and other associated products.
Aeris dynamics products are manufactured to cater for industries requirements meeting stringent shipping regulations as well as in reference to the guidance by leading industries and government bodies such as the FDA, WHO, IATA and ISTA.
Our vision is to be the leading global supply partner for cold chain temperature-controlled packaging. Our mission through our product and service excellence by technological innovation is to become the preferred choice of cold chain packaging solutions supply partner.



Adapt builds cloud-connected data loggers for cold chain monitoring.
Adapt loggers is established to support active cold chain operations with real-time asset intelligence data, which is essential to curb the losses.
Asset tracking, Logistics, Cold-chain, Biopharma, Food, and Cold storage companies use Adapt solutions to track and monitor their operations.
The patented end-to-end monitoring solutions give real-time status reports of the asset's location, temperature, humidity, tampering, and mishandling
Adapt provides Cloud storage and a Web-App interface for real-time data access and ease of reporting.URL or link to your website:



A world leader in the design and manufacture of high-performance temperature-controlled packaging systems for the transport of pharmaceutical products, EMBALL’ISO is now an expert of turnkey Reuse, Reverse Logistics and Rental solutions.
EMBALL’ISO’s worldwide presence across 4 continents, with 8 production sites (Brazil, China, France, Germany, India, Singapore, UK and the US), 14 Services Centre and collection points in more than 80 countries helps you reuse isothermal packaging while saving time and money.
We supply systems capable of carrying a single vial to airfreight pallet shippers available flat packed or fully assembled in new and innovative Logistics Business models.
EMBALL’ISO delivers quality everywhere, just like you.





Marken is a wholly owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations with 5,500 employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 59 locations worldwide, while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kit production.
Marken’s dedicated 2,000 staff members manage 135,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 11,500+ home healthcare visits. Additional services such as cell and gene supply chain services, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
Website: https://www.marken.com/





Terumo Pharmaceutical Solutions develops patient-oriented parenteral delivery solutions for therapeutic performance and safety Globally trusted for quality and precision, Terumo Pharmaceutical Solutions offers pharmaceutical and medical device manufacturers around the world comprehensive product design and development services, for primary container, injection, infusion therapy devices, and contract development and manufacturing services (CDMO).
We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral
drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies for
all parenteral applications. We provide sterile injectable contract development and manufacturing (CDMO) services from initial combination device design and formulation development to commercial manufacturing.
supporting better patient outcomes around the world.
We listen. We question. We deliver.



Nanghavi is a Joint Venture between Sweden based R&D company Nanologica and an Indian family owned business by the Sanghavi family, thereby deriving the name “NANGHAVI”.
We are in the business of manufacturing Analytical, Semi Preparative and Prep HPLC columns by. Our in-house capabilities boasts of manufacturing the silica, functionalizing it, packing the HPLC column & marketing and selling them.
We have an end-to-end capability of manufacturing from the raw material of spherical silica to the HPLC columns itself, we can have complete control over quality of the end product.





Pfanstiehl is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies.
Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC.
Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes.
Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally.
For more information about Pfanstiehl Inc, and their products and solutions, please contact us at [email protected] or visit www.Pfanstiehl.com”



- The 3M biopharmaceutical business is a subset of the 3M Separation and Purification Sciences Division which utilizes cutting edge 3M material science that pushes the boundaries of purification, filtration, and separation to support production, processes that change lives, and deliver quality solutions where it matters most.
- Our biopharma and materials science expertise can help you improve in-process purity, increase the yield of your product and lower manufacturing costs – so you can focus on bringing life-saving treatments to trial and market
- Biopharmaceutical Purification | 3M





Marken is a wholly owned subsidiary of UPS and is a critical part of UPS Healthcare. With Polar Speed and Marken included, the UPS Healthcare division staffs 128 locations with 5,500 employees worldwide. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 59 locations worldwide, while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kit production.
Marken’s dedicated 2,000 staff members manage 135,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries and territories and have orchestrated 11,500+ home healthcare visits. Additional services such as cell and gene supply chain services, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken’s unique position in the pharma and logistics industry.
Website: https://www.marken.com/



The world’s first “Vial-to-Harvest” Vaccine manufacturing platform with Linear scalability & ultimate process efficiency.
With decades of developmental efforts & experience in Bioprocess Engineering, we have solved the most critical problems of adherent cell culture processing i.e. 1) Lack of process scalability 2) Efficiency in terms of time to market 3) Affordability in terms of cost reduction in manufacturing process.
At OmniBRx, we have invented a novel bioreactor technology for large-scale biologics / vaccines production and stem-cell therapy use. The technology provides 10X Scalability, 6X efficiency and up to 90% cost reduction during upstream manufacturing processing.
Our patented “CellBRx®️” single-use bioreactors technology is the first-of-its-kind bioreactor devices offering a fully automated and robust platform for vaccine manufacturing with linear scalability of up to 200L bioreactor volume accommodating 1500 m2 of surface area per single-use bioreactor. The proprietary DBR technology employs parallel discs stacked on multiple shafts and the intermingling rotational arrangement of the discs ensures efficient mixing and homogeneity throughout the cell carrier matrix.
With the integrated seed-train development protocol, the technology becomes the first ever close-circuit fully-automated Vial-to-Harvest production platform. The CellBRx bioreactors can grow cells in high densities and recover them efficiently with complete end-to-end process automation.



Peli BioThermal is the first cold chain packaging solutions provider to make available a broad and comprehensive portfolio of patented and award-winning single-use and reusable thermal protection packaging solutions for the safe transport of pharmaceuticals, clinical trials, diagnostics, tissue, vaccines and blood supplies for the life science industry.
Collaboration with our clients is the first step to ensure we provide a solution that is built around the unique and very specific needs of your temperature-sensitive payloads. Our global services network provides consultation, support, engineering and deployment for your cold chain distribution challenges wherever they exist.
Peli BioThermal designs products to ensure our customers valuable payloads are kept in perfect condition, irrespective of external temperatures and conditions. They are designed to be strong and robust, to survive the rigors of international transport. With environmental issues in mind, we ensure that our design team specify the correct materials and consider ‘end of life’ recycling for all of our ranges, whether they are single use or reusable packaging systems.



HiMedia Laboratories Private Limited is an Indian origin Bioscience company headquartered in Mumbai, with presence across 150 countries. Its division, Animal Cell Culture has expertise in production of cell culture medium for mammalian & insect cell lines, in powdered and liquid formulations. Comprehensive design of experiments, raw material qualification and media production using automation and customization are our strengths. We supply serum free media for CHO, Vero, MDCK, HEK, PK-15, Vero, MRC-5 and BHK cell lines, most widely used for industrial production of recombinant proteins and vaccines. In addition, we also supply multi-compendial biochemicals and growth factors for Cell Culture.
To know more about our company please visit our website: www.himedialabs.com















Cold Chain Platform (CCP) is 100% focused on cold chain and logistics in the biopharmaceutical, life science, and healthcare industries. CCP services help global companies reach the right partners and get a firm foothold in the Asia Pacific. CCP works with global organizations to help them gain access to the APAC cold chain, logistics, and pharmaceutical market through a highly targeted audience.
Website: www.coldchainplatform.com



BioPharma Asia aims to keep its readers abreast of all developments in the areas of Manufacturing, Development, Quality Assurance, Outsourcing, and Regulatory Affairs, with only the highest quality articles and webinars written and presented by the most respected authors/presenters, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.



DBT/Wellcome Trust India Alliance (India Alliance) is an independent, dynamic public charity that funds research in health and biomedical sciences in India. India Alliance invests in transformative ideas and supportive research ecosystems to advance discovery and innovation to improve health and well-being. India Alliance encourages diversity, inclusivity, and transparency in science and works to facilitate engagement of science with society.



Express Healthcare, first published as Express Healthcare Management in January 2000, has grown to become the No.1 Business News Magazine for the healthcare industry. The editorial contents include: news, views, analysis and interviews, under main segments: Market, Strategy, Knowledge, Life, Radiology, Hospital Infra, [email protected] Besides this, we bring out a quarterly publication, called In Imaging for the radiology and imaging segment.



Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.












Present your expertise to the Asian Bioprocessing industry’s key stakeholders through a variety of available speaking packages.
Join the exhibition, and build an impressive presence among your potential clients.
Emphasize on your messages by promoting your brand alongside exhibition and thought leadership.
Engage with and build lasting connections that matter the most to your business.
Gain exclusive access to contacts of high-profile attendees through intimate networking opportunities.